Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey

Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the U.S. Based on SELECT Trial Criteria: Insights from the National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2023 Nov 11. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub ahead of print. PMID: 37950677.


Related Posts